Related Experiment Video
Updated: Feb 11, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Melanoma: What do all the mutations mean?
Elizabeth J Davis1, Douglas B Johnson1, Jeffrey A Sosman2
1Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Abstract:
Melanoma is one of the most highly mutated malignancies, largely as a function of its generation through ultraviolet light and other mutational processes. The wide array of mutations in both "driver" and "passenger" genes can present a confusing array of data for practitioners, particularly within the context of the recent revolutions in targeted and immune therapy. Although mutations in BRAF V600 clearly confer sensitivity to BRAF and mitogen-activated protein kinase kinase (MEK) inhibitors, the clinical implications of most other mutations are less often discussed and understood. In this review, we provide an overview of the high-frequency genomic alterations and their prognostic and therapeutic relevance in melanoma.
Insights
Melanoma, a highly mutated cancer, presents complex genomic data. This review clarifies high-frequency genetic alterations and their impact on prognosis and treatment for melanoma patients.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Melanoma is characterized by a high mutation burden, often linked to ultraviolet radiation exposure.
- The complexity of genetic alterations in melanoma poses challenges for clinical decision-making, especially with advancements in targeted and immune therapies.
- While BRAF V600 mutations predict response to BRAF and mitogen-activated protein kinase kinase (MEK) inhibitors, the significance of other mutations remains less understood.
Purpose of the Study:
- To provide an overview of frequent genomic alterations in melanoma.
- To discuss the prognostic and therapeutic relevance of these genetic changes.
- To aid practitioners in interpreting complex genomic data for melanoma treatment.
Main Methods:
- Literature review of high-frequency genomic alterations in melanoma.
- Analysis of existing data on prognostic and therapeutic implications.
- Synthesis of information regarding driver and passenger mutations.
Main Results:
- Identification of key high-frequency genomic alterations in melanoma.
- Correlation of specific mutations with patient prognosis.
- Linking genetic alterations to response or resistance to targeted therapies and immunotherapies.
Conclusions:
- Understanding melanoma's genomic landscape is crucial for effective treatment strategies.
- BRAF V600 mutations are key determinants of response to specific targeted therapies.
- Further research is needed to elucidate the clinical implications of a broader range of melanoma mutations.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations
Mutations in Microorganisms

